High-dose melphalan-based autotransplants for multiple myeloma: the Arkansas experience since 1989 in 3077 patients.

Abstract:

BACKGROUND:In this report, the authors describe their collective experience with melphalan-based autotransplants since the inception of their program at the University of Arkansas for Medical Sciences in 1989. METHODS:The authors evaluated the clinical outcomes of 3077 successive patients with multiple myeloma (MM) who underwent at least 1 melphalan-based autotransplantation at the University of Arkansas. Of these, 1078 patients were enrolled on front-line Total Therapy (TT) protocols (TT-P) TT1, TT2, and TT3; 1104 patients were entered on protocols for newly diagnosed or previously treated patients (non-TT-P); and 895 patients were treated off protocol (non-P). RESULTS:The 10-year overall survival (OS) rates after first transplantation were 41%, 19%, and 11% (P< .001) for the TT-P, non-TT-P, and non-P groups, respectively. In the TT-P group, the median OS was 72 months on TT1, was not reached at >or= 7 years on TT2, and was 88% at 2 years on TT3. Among 2683 patients with complete baseline data, absence of hypodiploidy/chromosome 13 deletion, beta-(2)-microglobulin <3.0 mg/L, C-reactive protein <6 mg/L, albumin >or= 3.0 g/dL, and platelet count >or= 100,000/microL all were associated independently with superior OS (P< .001), event-free survival (P< .001), and duration of complete remission (P< .001). CONCLUSIONS:The results from this large, single-institution experience demonstrated that >10-year OS was accomplished in >40% of all patients enrolled on TT-P, whereas such success was observed in only 15% of the remaining patients (including 25% in the presence of all 5 good-risk features). Superior outcomes with protocol-based, primary transplant regimens such as TT-P draw attention to the importance of applying the best available therapies upfront.

journal_name

Cancer

journal_title

Cancer

authors

Pineda-Roman M,Barlogie B,Anaissie E,Zangari M,Bolejack V,van Rhee F,Tricot G,Crowley J

doi

10.1002/cncr.23327

subject

Has Abstract

pub_date

2008-04-15 00:00:00

pages

1754-64

issue

8

eissn

0008-543X

issn

1097-0142

journal_volume

112

pub_type

杂志文章

相关文献

CANCER文献大全
  • Impact of postoperative prostate-specific antigen disease recurrence and the use of salvage therapy on the risk of death.

    abstract:BACKGROUND:This report evaluated whether biochemical recurrence (BCR) as a time-dependent covariate (t) after radical prostatectomy (RP) for prostate cancer was associated with the risk of death and whether salvage therapy with radiotherapy (RT) and/or hormonal therapy (HT) can lessen this risk METHODS:This was a retr...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.25013

    authors: Choueiri TK,Chen MH,D'Amico AV,Sun L,Nguyen PL,Hayes JH,Robertson CN,Walther PJ,Polascik TJ,Albala DM,Moul JW

    更新日期:2010-04-15 00:00:00

  • Gender differences in the effect of grief reactions and burnout on emotional distress among clinical oncologists.

    abstract:BACKGROUND:The current study was conducted to examine gender differences in the effect of grief reactions and burnout on emotional distress among clinical oncologists. METHODS:The participants included a convenience sample of 178 oncologists from Israel (52 of whom were women) and Canada (48 of whom were women). Oncol...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.30236

    authors: Granek L,Krzyzanowska MK,Nakash O,Cohen M,Ariad S,Barbera L,Levy R,Ben-David M

    更新日期:2016-12-01 00:00:00

  • Italian Cooperative Study for the treatment of children and young adults with localized Ewing sarcoma of bone: a preliminary report of 6 years of experience.

    abstract:BACKGROUND:In 1991, the Italian Association for Pediatric Hematology-Oncology and the National Council of Research (CNR) initiated an Italian Cooperative Study (SE 91-CNR Protocol) with the main objective of improving the overall survival (SUR) and the event free survival (EFS) of children and young adults with localiz...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1002/(sici)1097-0142(19990801)86:3<421::aid-cnc

    authors: Rosito P,Mancini AF,Rondelli R,Abate ME,Pession A,Bedei L,Bacci G,Picci P,Mercuri M,Ruggieri P,Frezza G,Campanacci M,Paolucci G

    更新日期:1999-08-01 00:00:00

  • Hypoxic radiosensitizers in radical radiotherapy for patients with bladder carcinoma: hyperbaric oxygen, misonidazole, and accelerated radiotherapy, carbogen, and nicotinamide.

    abstract:BACKGROUND:In animal models carbogen (normobaric 95% oxygen, 5% carbon dioxide) provides significant enhancement of local tumor control with fractionated radiotherapy. This approach to radiosensitization has been evaluated in the treatment of patients with bladder carcinoma using radical radiotherapy. METHODS:Sixty-on...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Hoskin PJ,Saunders MI,Dische S

    更新日期:1999-10-01 00:00:00

  • Obesity is associated with breast cancer in African-American women but not Hispanic women in South Los Angeles.

    abstract:BACKGROUND:Obesity is considered a risk factor for breast cancer. Modifying life styles that reduce obesity offers the potential for prevention and improved outcomes from cancer. The effects of obesity and breast cancer among African-American women and Hispanic women have been explored in a limited number of studies. T...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.25956

    authors: Sarkissyan M,Wu Y,Vadgama JV

    更新日期:2011-08-15 00:00:00

  • Relationship between cytokine gene single nucleotide polymorphisms and symptom burden and quality of life in lung cancer survivors.

    abstract:BACKGROUND:Previous research has demonstrated that many lung cancer survivors report difficulties with symptom control and experience a poor quality of life (QOL). Although recent studies have suggested a relationship of single nucleotide polymorphisms (SNPs) in several cytokine genes with cancer susceptibility and pro...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.25255

    authors: Rausch SM,Clark MM,Patten C,Liu H,Felten S,Li Y,Sloan J,Yang P

    更新日期:2010-09-01 00:00:00

  • Predictive value of oncogenic driver subtype, programmed death-1 ligand (PD-L1) score, and smoking status on the efficacy of PD-1/PD-L1 inhibitors in patients with oncogene-driven non-small cell lung cancer.

    abstract:BACKGROUND:This multicenter, retrospective study explored the value of oncogene driver subtype, programmed death-1 ligand (PD-L1) status, and smoking status for predicting which patients with oncogene-driven non-small cell lung cancer (NSCLC) would benefit from treatment with programmed death-1 (PD-1)/PD-L1 inhibitors....

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.31871

    authors: Ng TL,Liu Y,Dimou A,Patil T,Aisner DL,Dong Z,Jiang T,Su C,Wu C,Ren S,Zhou C,Camidge DR

    更新日期:2019-04-01 00:00:00

  • Long-term results of a prospective study on the treatment of medulloblastoma in adults.

    abstract:BACKGROUND:Because medulloblastoma (MB) is rare in adults, the few studies on this condition have been retrospective, and the follow-up has tended to be short. Furthermore, the different therapeutic strategies used in these patients has made it difficult to assess survival rates and prognostic factors. METHODS:In 1989...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.23003

    authors: Brandes AA,Franceschi E,Tosoni A,Blatt V,Ermani M

    更新日期:2007-11-01 00:00:00

  • Clonal divergence and genetic heterogeneity in clear cell renal cell carcinomas with sarcomatoid transformation.

    abstract:BACKGROUND:Approximately 5% of clear cell renal cell carcinomas contain components with sarcomatoid differentiation. It has been suggested that the sarcomatoid elements arise from the clear cell tumors as a consequence of clonal expansions of neoplastic cells with progressively more genetic alterations. Analysis of the...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.21288

    authors: Jones TD,Eble JN,Wang M,Maclennan GT,Jain S,Cheng L

    更新日期:2005-09-15 00:00:00

  • Short term treatment with Escherichia coli recombinant human granulocyte-macrophage-colony stimulating factor prior to chemotherapy for Hodgkin disease.

    abstract:BACKGROUND:Granulocyte-macrophage-colony stimulating factor (GM-CSF) administration stimulates the proliferation of hemopoietic progenitors. Shortly (48-96 hours) after its discontinuation, feedback phenomena occur and the progenitor proliferation rate drops below baseline levels. As the quiescence of hyperplastic bone...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验

    doi:10.1002/(sici)1097-0142(20000115)88:2<454::aid-cnc

    authors: Aglietta M,Montemurro F,Fagioli F,Volta C,Botto B,Cantonetti M,Racanelli V,Teofili L,Ferrara R,Amadori S,Castoldi GL,Dammacco F,Levis A

    更新日期:2000-01-15 00:00:00

  • Sequential therapy with sorafenib and sunitinib in renal cell carcinoma.

    abstract:BACKGROUND:Sunitinib and sorafenib are small-molecule tyrosine kinase inhibitors (TKI) with antitumor activity in advanced renal cell carcinoma. A retrospective study was conducted to assess the response of renal cell carcinoma to sequential treatment with these two agents. METHODS:Tumor response was evaluated by usin...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.24009

    authors: Dudek AZ,Zolnierek J,Dham A,Lindgren BR,Szczylik C

    更新日期:2009-01-01 00:00:00

  • Treatment of small-cell lung cancer in elderly patients.

    abstract::Small-cell lung cancer (SCLC) represents 15% to 20% of all lung carcinomas. Approximately 30% to 40% of these cases are diagnosed in patients older than 70 years of age. Staging of SCLC classifies patients as having either limited or extensive-stage disease. The standard treatment for limited-stage disease is platinum...

    journal_title:Cancer

    pub_type: 杂志文章,评审

    doi:10.1002/cncr.24833

    authors: Pallis AG,Shepherd FA,Lacombe D,Gridelli C

    更新日期:2010-03-01 00:00:00

  • Barriers and incentives for primary care physicians in cancer prevention and detection.

    abstract::The American Cancer Society estimates that nearly a million new cases of cancer will occur and that approximately a half million lives will be lost in 1987. These figures may double by the year 2000 primarily because of our aging population, with age being the leading risk factor for cancer. It is believed that the ma...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19880601)61:11+<2382::aid-cncr28

    authors: Williams PA,Williams M

    更新日期:1988-06-01 00:00:00

  • Prognostic diversity among cytogenetic abnormalities in myelofibrosis with myeloid metaplasia.

    abstract:BACKGROUND:Approximately 30-50% of patients with myelofibrosis with myeloid metaplasia (MMM) demonstrate detectable cytogenetic abnormalities, the prognostic value of which has not been completely defined by previous retrospective studies. The current prospective study addresses this issue in the context of currently a...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.21358

    authors: Tefferi A,Dingli D,Li CY,Dewald GW

    更新日期:2005-10-15 00:00:00

  • Estimating the magnitude of colorectal cancers prevented during the era of screening: 1976 to 2009.

    abstract:BACKGROUND:Ideally, screening detects cancer at a more curable stage and, as a result, decreases the rate of subsequent diagnosis at a late stage. Although it is suggested that some cancer screening tests have led to substantial increases in early-stage incidence with only marginal reductions in late-stage incidence (e...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.28794

    authors: Yang DX,Gross CP,Soulos PR,Yu JB

    更新日期:2014-09-15 00:00:00

  • Glycoproteins and human cancer: II. Correlation between circulating level and disease status.

    abstract::Many cancer patients have elevated serum protein and sialic acid (N-acetyl neuraminic acid, NANA) levels. Serial determinations were performed, using serum treated with perchloric acid from 34 patients with widespread metastatic disease. Six of six patients who underwent debulking surgery had a drop in their serum NAN...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19810115)47:2<324::aid-cncr28204

    authors: Harvey HA,Lipton A,White D,Davidson E

    更新日期:1981-01-15 00:00:00

  • Mucin core protein expression in extrahepatic bile duct carcinoma is associated with metastases to the liver and poor prognosis.

    abstract:BACKGROUND:Curative resection does not guarantee long term survival for the patient with extrahepatic bile duct carcinoma because of the possibility of metastases to the liver (LM). Expression of mucin core protein-1 (MUC1), sialyl-Le(x), and sialosyl-Tn in bile duct carcinoma was determined and compared with LM and pr...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/(sici)1097-0142(19991115)86:10<1966::aid-c

    authors: Takao S,Uchikura K,Yonezawa S,Shinchi H,Aikou T

    更新日期:1999-11-15 00:00:00

  • The natural history of breast carcinoma in patients with > or = 10 metastatic axillary lymph nodes before and after the advent of adjuvant therapy: a multiinstitutional retrospective study.

    abstract:BACKGROUND:The majority of patients with breast carcinoma with > or = 10 metastatic axillary lymph nodes (ALNs) develop recurrent disease within 5 years from diagnosis. The purpose of the current study, performed retrospectively, was to characterize the natural history of this subset of patients, both before and after ...

    journal_title:Cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1002/cncr.21182

    authors: Montero AJ,Rouzier R,Lluch A,Theriault RL,Buzdar AU,Delaloge S,Bermejo B,Le M,Kau SW,Dunant A,Arriagada R,Spielmann M,Garcia-Conde J,Sahin AA,Singletary SE,Hortobagyi GN,Valero V

    更新日期:2005-07-15 00:00:00

  • Combination therapy of intraarterial 5-fluorouracil and systemic interferon-alpha for advanced hepatocellular carcinoma with portal venous invasion.

    abstract:BACKGROUND:Hepatocellular carcinoma (HCC) with portal venous invasion (PVI) has a very poor prognosis, with a median survival of 3 months and virtually no survival at 1 year. The combination of intraarterial 5-fluorouracil (FU) and systemic interferon-alpha (IFNalpha) was recently reported to be effective against HCC w...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/cncr.21832

    authors: Obi S,Yoshida H,Toune R,Unuma T,Kanda M,Sato S,Tateishi R,Teratani T,Shiina S,Omata M

    更新日期:2006-05-01 00:00:00

  • Deficiencies in myeloid antigen-presenting cells in women with cervical squamous intraepithelial lesions.

    abstract:BACKGROUND:There is little information on the function of dendritic cells in women with human papillomavirus (HPV)-related cervical squamous intraepithelial lesions (SILs). In the current study the functions of dendritic cells in the development of T-cell immunity in women with cervical SILs were assessed. METHODS:The...

    journal_title:Cancer

    pub_type: 杂志文章,多中心研究

    doi:10.1002/cncr.22092

    authors: Lee BN,Follen M,Rodriquez G,Shen DY,Malpica A,Shearer WT,Reuben JM

    更新日期:2006-09-01 00:00:00

  • Preparation of murine B7.1-glycosylphosphatidylinositol and transmembrane-anchored staphylococcal enterotoxin. A dual-anchored tumor cell vaccine and its antitumor effect.

    abstract:BACKGROUND:The authors have previously reported a tumor cell vaccine modified with superantigen staphylococcal enterotoxin A (SEA) and its antitumor effect. The tumor cell vaccines modified with multiple immune activators frequently elicited stronger immune responses against established tumors than single-modified vacc...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.20943

    authors: Yi P,Yu H,Ma W,Wang Q,Minev BR

    更新日期:2005-04-01 00:00:00

  • Anticancer effects of arterial administration of the anticancer agent SMANCS with lipiodol on metastatic lymph nodes.

    abstract::A new method of arterially administering an oily anticancer agent was successfully established for the selective targeting of metastatic lymph nodes. A high molecular weight anticancer agent, a conjugate of copolymer (styrene maleic acid) to neocarzinostatin (SMANCS) was prepared in our laboratory and dissolved in a l...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19870501)59:9<1560::aid-cncr2820

    authors: Ohtsuka N,Konno T,Miyauchi Y,Maeda H

    更新日期:1987-05-01 00:00:00

  • Techniques and predictive models to improve prostate cancer detection.

    abstract::The use of prostate-specific antigen (PSA) as a screening test remains controversial. There have been several attempts to refine PSA measurements to improve its predictive value. These modifications, including PSA density, PSA kinetics, and the measurement of PSA isoforms, have met with limited success. Therefore, com...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.24357

    authors: Herman MP,Dorsey P,John M,Patel N,Leung R,Tewari A

    更新日期:2009-07-01 00:00:00

  • BACON (bleomycin, adriamycin, CCNU, oncovin and nitrogen mustard) in squamous lung cancer. Experience in fifty patients.

    abstract::Fifty patients with inoperable squamous carcinoma of the lung. 38 with extensive, and 12 with limited disease, were treated with BACON. Tumor regression greater than 50% was observed in 17 patients (45%) with extensive, and four patients (33%) with limited disease. Stabilization of disease for greater than or equal to...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/1097-0142(197603)37:3<1237::aid-cncr282037

    authors: Livingston RB,Fee WH,Einhorn LH,Burgess MA,Freireich EJ,Gottlieb JA,Farber MO

    更新日期:1976-03-01 00:00:00

  • Identifying breast cancer patients most likely to benefit from aromatase inhibitor therapy after adjuvant radiation and tamoxifen.

    abstract:BACKGROUND:The purpose of the current study was to examine patient selection for an aromatase inhibitor in breast cancer patients who were free from adverse events 5 years after treatment with tamoxifen. METHODS:In all, 471 women were treated with breast-conserving surgery, axillary lymph node dissection, and radiatio...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.22291

    authors: Freedman GM,Anderson P,Li T,Ross E,Swaby R,Goldstein L

    更新日期:2006-12-01 00:00:00

  • Nucleolar organizer regions in precancerous and cancerous lesions of the bronchus.

    abstract::Using a silver staining technique, nucleolar organizer region-associated proteins (Ag-NOR) were studied in paraffin sections of five specimens of normal bronchial epithelium, eight of atypical squamous metaplasia, five of carcinoma in situ, and seven of microinvasive squamous cell carcinoma. The mean number of Ag-NOR ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19910115)67:2<472::aid-cncr28206

    authors: Abe S,Ogura S,Kunikane H,Suko N,Watanabe N,Nakajima I,Kawakami Y,Inoue K

    更新日期:1991-01-15 00:00:00

  • Cytologic factors associated with prognosis in patients with peripheral adenocarcinoma of the lung measuring 3 cm or less in greatest dimension.

    abstract:BACKGROUND:Recently, peripheral lung adenocarcinomas (PLA) measuring < or = 3 cm in greatest dimension often have been diagnosed using diagnostic radiology. The objective of the current study was to determine which cytologic factors are associated with a favorable outcome and an unfavorable outcome in patients with PLA...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.20686

    authors: Kobayashi Y,Yokose T,Kawamura K,Iwasaki S,Murata Y,Onuma S,Hasebe T,Nagai K,Sasaki S,Ochiai A

    更新日期:2005-02-25 00:00:00

  • Concurrent vinblastine and radiation therapy in bladder cancer.

    abstract:BACKGROUND:Since mid-1987, 29 patients with invasive transitional cell carcinoma of the urinary bladder (T1-3 N0-X M0) were treated with concurrent radiation therapy (RT) (target dose [TD], 62-66 Gy) 1.8-2.0 Gy/day for 5 days a week with a break in the middle of treatment of 2-3 weeks and vinblastine weekly 2 mg/5-12 h...

    journal_title:Cancer

    pub_type: 临床试验,杂志文章

    doi:10.1002/1097-0142(19921215)70:12<2885::aid-cncr282

    authors: Kragelj B,Jereb B,Kragelj L,Stanonik M

    更新日期:1992-12-15 00:00:00

  • Prediction of outcome in metastatic breast cancer treated with adriamycin combination chemotherapy.

    abstract::Univariate and multivariate regression methods were used to analyze 17 potential clinical prognostic factors among 138 patients with advanced breast cancer who received Adriamycin-cyclophosphamide combination chemotherapy between 1973 and 1977 at the University of Arizona. Follow-up of patients was through September 1...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/1097-0142(19801201)46:11<2380::aid-cncr282

    authors: Nash CH 3rd,Jones SE,Moon TE,Davis SL,Salmon SE

    更新日期:1980-12-01 00:00:00

  • Physical fitness and modifiable cardiovascular disease risk factors in survivors of childhood cancer: A report from the SURfit study.

    abstract:BACKGROUND:Childhood cancer survivors are at risk for cardiovascular disease (CVD) because of intensive cancer therapies often accompanied by an unhealthy lifestyle. This study was aimed at 1) describing modifiable CVD risk factors in survivors and 2) investigating the association between different aspects of physical ...

    journal_title:Cancer

    pub_type: 杂志文章

    doi:10.1002/cncr.33351

    authors: Schindera C,Zürcher SJ,Jung R,Boehringer S,Balder JW,Rueegg CS,Kriemler S,von der Weid NX

    更新日期:2021-01-06 00:00:00